Investigates mir-1246's impact on clinical outcomes in NRDS, suggesting its role as a biomarker for prognosis.
miR-1246 is overexpressed in NRDS children and is associated with disease onset and clinical outcomes. miR-1246 may be a potential biomarker for assessing the prognosis of NRDS children.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: